Antigen-Antibody Reactions 2

An antigen–antibody reaction begins when an antibody specifically recognizes and binds to an antigenic determinant. In blood group serology, the antigen is commonly a structure expressed on the red blood cell membrane, while the antibody is present in plasma or serum or supplied as a laboratory reagent.

The region of an antigen recognized by an antibody is called an epitope, while the corresponding antigen-binding region of the antibody is called the paratope. Their interaction depends on complementary chemical and structural characteristics rather than a permanent covalent bond.

The specificity of the reaction means that an antibody generally reacts more strongly with its corresponding antigen than with unrelated structures. However, closely related antigens may sometimes produce cross-reactivity when they share sufficiently similar epitopes.

Affinity refers to the strength of a single antigen–antibody binding interaction. Avidity refers to the combined functional strength of multiple antigen–antibody interactions and is particularly important when antibodies and antigens have multiple binding sites.

The first important event is sensitization, in which antibody binds to antigen on the red cell membrane. Sensitization may occur rapidly and may be invisible to the naked eye because the cells have not yet formed sufficiently large aggregates.

Visible haemagglutination occurs when sensitized red cells become sufficiently cross-linked to form aggregates that can be observed macroscopically. Therefore, a test may contain antibody-coated red cells without producing obvious agglutination.

The distinction can be summarized as follows:

• Sensitization: antibody has attached to antigen on the red cell.
• Agglutination: antibody has produced visible cross-linking of red cells.
• Haemolysis: red cells have been damaged or destroyed, commonly following complement activation in an appropriate reaction.

This distinction is particularly important in antiglobulin testing. An immunoglobulin G (IgG) antibody may sensitize red cells without producing visible agglutination until an anti-human globulin reagent is added.

Visible agglutination depends on the formation of a three-dimensional antigen–antibody lattice. Antibodies must bind to antigens on more than one red cell, allowing the cells to become linked into progressively larger aggregates.

Red cells naturally remain separated in suspension partly because their surfaces carry a net negative electrical charge. The electrostatic repulsion between adjacent cells is described in relation to the zeta potential, which contributes to the distance between red cells.

IgM molecules are relatively large, pentameric antibodies with multiple antigen-binding sites and can often bridge the distance between red cells effectively. This is one reason many IgM antibodies produce direct agglutination under suitable conditions.

IgG molecules are smaller and generally cannot overcome the red-cell separation sufficiently to produce direct visible agglutination in saline. Nevertheless, IgG can bind strongly to red cell antigens and produce sensitization, which can subsequently be demonstrated using the antiglobulin technique.

Blood group serology uses several observable outcomes of antigen–antibody interaction. The endpoint depends on the antibody, antigen, test environment, and whether additional reagents are present.

Direct Agglutination

Direct agglutination occurs when antibody binds to particulate antigens and directly produces visible clumping. A common transfusion-science example is the reaction of anti-A with red cells expressing A antigen during ABO grouping.

The basic reaction is:

1. Red cell antigen + corresponding antibody → sensitization → red cell cross-linking → visible haemagglutination

A positive direct agglutination reaction demonstrates that the tested red cells reacted with the reagent antibody under the conditions used. It does not, by itself, establish every characteristic of the patient’s ABO or other blood group system without appropriate additional testing and controls.

Antiglobulin-Phase Reactions

The antiglobulin test, also called the indirect antiglobulin test when used to detect antibodies in serum or plasma, is designed to demonstrate red cells that have become sensitized but are not visibly agglutinated.

After the patient’s antibody has been allowed to react with reagent red cells, unbound antibody is removed by washing. Anti-human globulin reagent is then added. This reagent can bridge human immunoglobulin or complement components attached to the red cells, producing visible agglutination.

The general sequence is:

1. Mix serum or plasma containing possible antibody with appropriate reagent red cells.
2. Incubate under the specified conditions.
3. Allow antibody to bind to corresponding red cell antigens.
4. Wash the red cells to remove unbound immunoglobulin.
5. Add anti-human globulin reagent.
6. Centrifuge according to the validated procedure.
7. Gently resuspend the cell button and examine for agglutination.
8. Record and grade the reaction.
9. Validate negative antiglobulin reactions with appropriate check cells when required by the method.

A positive antiglobulin reaction demonstrates detectable sensitization and subsequent agglutination under the test conditions. It does not, by itself, identify the antibody or prove that the antibody is clinically significant.

Complement Activation and Haemolysis

Some antigen–antibody reactions activate the complement system, a group of plasma proteins capable of amplifying immune reactions. Depending on the antibody and antigen involved, complement activation may result in deposition of complement components on the red cell or progress to membrane damage and haemolysis.

Haemolysis is therefore another possible serological endpoint. In a laboratory reaction, visible haemolysis may appear as a reddish or pink supernatant after the red cells have been damaged.

The presence of haemolysis demonstrates that red cell destruction occurred during the reaction. It does not automatically identify the responsible antibody because several antibodies and reaction conditions may produce complement-mediated effects.

Antigen–Antibody Ratio

The relative concentrations of antigen and antibody affect lattice formation. Very high concentrations of antibody or antigen can sometimes produce weak or absent visible reactions because effective cross-linking is reduced.

This phenomenon is commonly described using the concepts of prozone and postzone. The prozone refers to weak reactions associated with antibody excess, whereas the postzone refers to weak reactions associated with antigen excess. An optimal relative concentration generally provides the most effective lattice formation.

Temperature

Temperature influences antibody binding and reaction kinetics. Some antibodies react preferentially at colder temperatures, while many clinically important red cell antibodies are most effectively detected at approximately 37°C, the normal core body temperature.

The appropriate incubation temperature therefore depends on the testing objective and the antibody characteristics being investigated. Test conditions should follow the validated method and reagent manufacturer’s instructions.

pH and Ionic Strength

Antigen–antibody binding is influenced by the chemical environment of the reaction mixture. Extreme pH can interfere with protein structure or antibody binding and is therefore unsuitable for routine serological testing.

Ionic strength also affects the electrostatic environment surrounding red cells and antibodies. Low ionic strength media can enhance the uptake of certain antibodies onto red cells and may shorten the time required for some reactions to reach detectable sensitization.

Incubation and Centrifugation

Incubation provides time for antibodies to interact with corresponding antigens. Insufficient incubation can result in weak or missed reactions, particularly when detecting antibodies that react slowly.

Incubation conditions should therefore be standardized. Excessive or inappropriate incubation may also introduce problems, including increased nonspecific reactions or loss of reaction stability in some systems.

Centrifugation brings red cells into closer physical contact and can enhance the visibility of agglutination. It is particularly important in tube testing because appropriately controlled centrifugation helps separate true agglutination from a simple loose cell sediment.

The centrifuge speed and duration must be validated for the specific method. Excessive centrifugation can make negative cell buttons difficult to resuspend and may lead to misinterpretation, whereas insufficient centrifugation can produce weak or poorly defined reactions.

Enhancement media are used to increase the sensitivity or efficiency of selected antigen–antibody reactions.

Common examples include:

• Low ionic strength solution (LISS): reduces ionic strength and can increase the rate of antibody uptake by red cells.
• Polyethylene glycol (PEG): concentrates antibody around the red cells by reducing available water and can enhance detection of certain IgG antibodies.
• Albumin: may reduce the effective separation between red cells and facilitate some agglutination reactions.

Enhancement media must be used according to the validated test system because their effects are antibody- and method-dependent.

Proteolytic enzymes such as papain or ficin can modify red cell membrane structures and alter the expression or accessibility of some blood group antigens. Enzyme treatment may therefore enhance some antibody reactions while weakening or destroying the reactivity of others.

Enzymes are useful as supplementary techniques in antibody investigations but should not be assumed to reproduce the reactivity of an untreated test. Their results must be interpreted alongside other serological findings.

A basic tube method illustrates how the stages of an antigen–antibody reaction are translated into a laboratory result. Exact volumes, concentrations, incubation times, centrifugation conditions, washing procedures, and reagents vary according to the validated procedure being used.

A generalized tube-test sequence is:

1. Identify and label the test tube correctly according to the specimen, reagent red cells, and test being performed.
2. Add the appropriate serum or plasma and reagent red cells in the validated proportions.
3. Mix the contents gently and thoroughly.
4. Incubate at the specified temperature and for the specified period when the method requires an incubation phase.
5. Centrifuge using the validated time and force.
6. Resuspend the cell button gently without excessively disrupting genuine agglutinates.
7. Observe for agglutination or haemolysis and determine the reaction grade.
8. For antiglobulin testing, wash the cells appropriately to remove unbound antibody before adding anti-human globulin reagent.
9. Add anti-human globulin reagent, centrifuge, and read promptly according to the validated procedure.
10. Validate negative antiglobulin reactions with check cells when required and record the final result.

A tube reaction should never be interpreted solely from the presence or absence of a cell button. The appearance of the suspension after gentle resuspension, the distribution and size of aggregates, and the presence or absence of haemolysis are important parts of interpretation.

Agglutination is commonly graded according to the strength and appearance of the reaction. Although grading systems may vary slightly between laboratories, a typical interpretation distinguishes strong, moderate, weak, mixed-field, and negative reactions.

A generalized grading pattern is:

• 4+: very large agglutinates; background suspension is usually clear.
• 3+: several large agglutinates with relatively clear surrounding fluid.
• 2+: many medium-sized agglutinates with some free cells.
• 1+: small agglutinates with many free red cells.
• Weak or microscopic reaction: very small aggregates requiring careful observation or an appropriate optical aid.
• 0: no agglutination; cells remain as a smooth suspension or compact button after centrifugation.
• Mixed-field: two distinguishable red cell populations may be present, with one population agglutinated and another remaining free.

Reaction grading is descriptive rather than diagnostic. A stronger reaction does not automatically mean that an antibody is more clinically significant, nor does a weak reaction automatically indicate an unimportant antibody.

A positive reaction demonstrates that the test system detected the specified serological endpoint under the conditions used. It does not by itself prove:

• The precise antibody specificity.
• That the antibody is clinically significant.
• That the reaction is responsible for a patient’s clinical condition.
• That the tested sample represents the patient’s complete antibody profile.
• That transfusion compatibility can be determined from that single reaction alone.

Interpretation must therefore consider the test method, controls, reaction pattern, antigen profile of the test cells, and the wider transfusion-testing context.

False-positive and false-negative reactions can arise from technical, reagent-related, specimen-related, or biological factors.

Potential Causes of False-Positive Reactions

• Contaminated reagents or equipment.
• Improperly cleaned glassware or test materials.
• Fibrin or particulate material in the specimen.
• Spontaneous red cell aggregation.
• Rouleaux.
• Incorrect reagent or specimen identification.
• Excessive centrifugation.
• Contaminated saline or enhancement medium.
• Failure to follow the specified testing procedure.

Potential Causes of False-Negative Reactions

• Incorrect serum-to-cell ratio.
• Insufficient incubation.
• Unsuitable incubation temperature.
• Inadequate washing before antiglobulin testing.
• Failure to add or deterioration of anti-human globulin reagent.
• Excessive delay before reading the reaction.
• Weak or deteriorated reagent red cells.
• Inappropriate centrifugation.
• Failure to use an appropriate enhancement system.
• Very weak antibody concentration.
• Antigen loss or weak antigen expression.

Quality practice requires more than obtaining a visible reaction. It includes correct specimen identification, reagent storage, reagent quality checks, validated equipment, appropriate controls, standardized procedures, accurate timing, correct centrifugation, careful washing, immediate reading when required, and complete documentation.

Controls are particularly important because they help determine whether an observed reaction is attributable to the intended antigen–antibody interaction rather than an unrelated technical problem. In antiglobulin testing, appropriate check cells can demonstrate that a negative reaction is technically valid and that the antiglobulin reagent was capable of producing a reaction.

Antigen–antibody reactions form the basis of much of transfusion science. Antibody binding begins with specific recognition between an epitope and paratope, but binding alone may not produce visible agglutination. The laboratory must therefore distinguish sensitization, agglutination, and haemolysis as different possible outcomes.

Reaction strength depends on the biological properties of the antibody and antigen as well as laboratory conditions such as antigen–antibody ratio, temperature, pH, ionic strength, incubation, centrifugation, enhancement media, and enzyme treatment. Direct agglutination may be observed immediately with suitable antibodies, while IgG sensitization may require an antiglobulin phase for demonstration.

For the medical laboratory scientist, correct interpretation requires more than recognizing a positive tube. The reaction must be graded accurately, controls must be satisfactory, technical errors must be excluded, and the result must be interpreted within the appropriate blood group serology procedure.